FDA inspection
WuXi Advanced Therapies: FDA inspection ending Dec 27, 2002
FDA inspection 254516 · Voluntary Action Indicated (VAI) · Philadelphia, PA
Key facts
| Inspection ID | 254516 |
|---|---|
| Firm | WuXi Advanced Therapies |
| FEI number | 1000122198 |
| Address | 4751 League Island Blvd |
| City | Philadelphia |
| State | PA |
| ZIP | 19112-1220 |
| Fiscal year | 2003 |
| Inspection end date | Dec 27, 2002 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Devices, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data